DRAK2 Antikörper
-
- Target Alle DRAK2 (STK17B) Antikörper anzeigen
- DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser DRAK2 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant protein of human STK17B
- Isotyp
- IgG
- Top Product
- Discover our top product STK17B Primärantikörper
-
anti-serine/threonine Kinase 17b (STK17B) (AA 272-372) antibody
STK17B Reaktivität: Human ELISA, WB, IF, IHC (p) Wirt: Maus Monoclonal 2C3 unconjugated
anti-serine/threonine Kinase 17b (STK17B) (AA 342-371), (C-Term) antibodySTK17B Reaktivität: Human, Maus WB, IF, IHC (p) Wirt: Kaninchen Polyclonal RB3049 unconjugated
anti-serine/threonine Kinase 17b (STK17B) (AA 235-366) antibodySTK17B Reaktivität: Human ELISA, WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (Internal Region) antibodySTK17B Reaktivität: Human, Maus, Ratte ELISA, WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (AA 1-372) antibodySTK17B Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (C-Term) antibodySTK17B Reaktivität: Human, Maus, Ratte ELISA, WB, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (Internal Region) antibodyVerified STK17B Reaktivität: Human ELISA, WB Wirt: Ziege Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (Center) antibodySTK17B Reaktivität: Human, Maus, Ratte, Rind (Kuh) WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (C-Term) antibodySTK17B Reaktivität: Human WB, IF, EIA Wirt: Kaninchen Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (Internal Region) antibodySTK17B Reaktivität: Human, Maus, Ratte ELISA, WB, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- IHC 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
- Andere Bezeichnung
- DRAK2 (STK17B Produkte)
- Synonyme
- zgc:65989 antikoerper, STK17B antikoerper, DRAK2 antikoerper, Drak2 antikoerper, 3110009A03Rik antikoerper, AI120141 antikoerper, serine/threonine kinase 17b (apoptosis-inducing) antikoerper, serine/threonine kinase 17b antikoerper, stk17b antikoerper, STK17B antikoerper, Stk17b antikoerper
- Hintergrund
- The full-lengthSTK17BcDNA clone encodes a deduced 372-amino acid protein with a molecular mass of 42.34 kD. The putative kinase domain is located at the N terminus and contains all 11 subdomains conserved among ser/thr kinases. STK17A andSTK17Bshare 59.7 % amino acid identity.Northern blot analysis revealed that STK17B was expressed in various tissues, such as heart, placenta, liver, and pancreas, as different-sized transcripts, presumably due to differences in the 3-prime untranslated region. Transient transfection of COS-7 cells showed that STK17B localized in nuclei. Phosphorylates myosin light chains. Acts as a positive regulator of apoptosis.
- UniProt
- O94768
-
